Diagnostic Characterization and Evolution of "Triple Negative" Thrombocytosis (CASTETTE)
Active, not recruiting
- Conditions
- Myeloproliferative Neoplasm
- Registration Number
- NCT06481332
- Lead Sponsor
- University Hospital, Brest
- Brief Summary
Evaluation of Event free survival in patients with triple-negative thrombocytosis
- Detailed Description
Patients with non-reactive thrombocytosis, explored at least by bone marrow biopsy and NGS panel will be included. Clinical and biological characteristics as well as evolution will be recorded retrospectively.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- Patients with non reactive thrombocytosis for at least 6 months
- availability of bone marrow biopsy and NGS panel
Exclusion Criteria
- Unable to consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Event-free survival 3 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chu Brest
🇫🇷Brest, France